Congratulations! Shenzhen Neoimmune Co., Ltd's product has been selected for the 2024 VBEF Healthcare Industry Innovation Product List.

2024-05-10 15:58:24 neoimmune 39

From May 8th to 10th, 2024, the 8th Future Healthcare Ecosystem Expo (VBEF) took place in Beijing. The conference unveiled the 2024 Healthcare Industry Innovation Product List, with Shenzhen Neoimmune Co., Ltd's hematologic malignancy minimal residual disease detection product (NEO-MRD) being included among them.


图片关键词




The VBEF and the Healthcare Industry Innovation Product List for Healthcare are derived from the Future Medical 100 Strong Conference, which has now been held for eight editions. The "Future Medical 100 Strong Series Lists and Awards" have become the authoritative and objective evaluation criteria and system for China's healthcare innovation industry, making it the most watched annual selection in the industry and capital sectors in the field of life and health.


The "Healthcare Industry Innovation Product List" is the first list released by VBEF, aiming to discover and showcase healthcare innovations and solutions that represent the technological advancements, high domestic substitution potential, ability to address unmet clinical needs, global competitiveness, and industry-leading effects of China's healthcare industry.


Shenzhen Neoimmune Co., Ltd's product, which was selected this time, the NEO-MRD, a minimal residual disease detection product for hematologic malignancies, successfully made the 2024 VBEF Healthcare Industry Innovation Product List by virtue of being "the first CE-certified MRD detection product for hematologic malignancies in China."


图片关键词






Contact Us

8/F, Block A, Hengtemei Building, No. 3 Ganli Road, Longgang District, Shenzhen; 402, Kelente R&D Building, Ganli Road, Longgang District, Shenzhen.

TEL: 0755-8453-4802

EMAIL

query@neoimmune.cn